Literature DB >> 7674874

Quantification of tolerance to lower body negative pressure in a healthy population.

J T Lightfoot1, K M Tsintgiras.   

Abstract

Subtolerance and presyncopal lower body negative pressure (LBNP) has been used extensively to investigate the effect of various forms of exercise training on central hypovolemic tolerance. However, there are no population data concerning LBNP tolerance, and the validity of common LBNP tolerance indices has not been investigated. LBNP tolerance data from 86 males and 33 females were analyzed. All LBNP exposures were terminated with the onset of presyncopal signs and/or symptoms. LBNP tolerance was quantified using duration of exposure (DNP), maximal negative pressure tolerated (MNP, cumulative stress index (CSI), and the LBNP tolerance index (LTI). Average (+/- SD) LBNP tolerance was 22.12 +/- 5.01 min (DNP), -77 +/- 16 mm Hg (MNP), 975 +/- 402 mm Hg.min-1 (CSI), or 222 +/- 50 mm Hg.min-1 (LTI). All cardiovascular parameters exhibited the same responses as have been documented in the literature. While DNP, MNP, and LTI were normally distributed, CSI in this population was not normally distributed. Age, weight, height, gender, and VO2peak were not associated with LBNP tolerance. Compared to this population, it appears that the subjects that have participated in previous LBNP tolerance studies have had abnormally high LBNP tolerances and that the LTI is the most valid index of LBNP tolerance. Furthermore, in this population LBNP tolerance could not be predicted from physical characteristics.

Entities:  

Mesh:

Year:  1995        PMID: 7674874

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  8 in total

1.  Greater orthostatic tolerance in young black compared with white women.

Authors:  Kumba Hinds; Nina S Stachenfeld
Journal:  Hypertension       Date:  2010-05-10       Impact factor: 10.190

2.  Training mode does not affect orthostatic tolerance in chronically exercising subjects.

Authors:  Warren D Franke; Kimberly K Mills; Kichang Lee; Juliane P Hernandez
Journal:  Eur J Appl Physiol       Date:  2003-02-28       Impact factor: 3.078

3.  Human muscle sympathetic neural and haemodynamic responses to tilt following spaceflight.

Authors:  Benjamin D Levine; James A Pawelczyk; Andrew C Ertl; James F Cox; Julie H Zuckerman; André Diedrich; Italo Biaggioni; Chester A Ray; Michael L Smith; Satoshi Iwase; Mitsuru Saito; Yoshiki Sugiyama; Tadaaki Mano; Rong Zhang; Kenichi Iwasaki; Lynda D Lane; Jay C Buckey; William H Cooke; Friedhelm J Baisch; Dwain L Eckberg; C Gunnar Blomqvist
Journal:  J Physiol       Date:  2002-01-01       Impact factor: 5.182

4.  Rat strains bred for low and high aerobic running capacity do not differ in their survival time to hemorrhage.

Authors:  Harold G Klemcke; Kathy L Ryan; Steven L Britton; Lauren G Koch; Michael A Dubick; Victor A Convertino
Journal:  Exp Biol Med (Maywood)       Date:  2009-08-05

5.  The impact of acute central hypovolemia on cerebral hemodynamics: does sex matter?

Authors:  Alexander J Rosenberg; Victoria L Kay; Garen K Anderson; My-Loan Luu; Haley J Barnes; Justin D Sprick; Hannah B Alvarado; Caroline A Rickards
Journal:  J Appl Physiol (1985)       Date:  2021-04-29

6.  A comparison of protocols for simulating hemorrhage in humans: step versus ramp lower body negative pressure.

Authors:  Alexander J Rosenberg; Victoria L Kay; Garen K Anderson; Justin D Sprick; Caroline A Rickards
Journal:  J Appl Physiol (1985)       Date:  2020-11-19

7.  Cardiovascular Response Patterns to Sympathetic Stimulation by Central Hypovolemia.

Authors:  Anne-Sophie G T Bronzwaer; Jasper Verbree; Wim J Stok; Mark A van Buchem; Mat J A P Daemen; Matthias J P van Osch; Johannes J van Lieshout
Journal:  Front Physiol       Date:  2016-06-20       Impact factor: 4.566

8.  Slower Lower Limb Blood Pooling Increases Orthostatic Tolerance in Women with Vasovagal Syncope.

Authors:  Johan Skoog; Helene Zachrisson; Toste Länne; Marcus Lindenberger
Journal:  Front Physiol       Date:  2016-06-14       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.